Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prophylaxis CTLA4-ig reduces anti-AAV neutralizing antibodies in AAV gene therapy for hemophilia

Dandan Yu, Bingqi Xu, Wei Liu, Feng Xue, Chen Yunfei, Xiaofan Liu, Mankai Ju, Sun Ting, Xinyue Dai, Huan Dong, Wenjing Gu, Yang Renchi, Xiao Xiao, Xia Wu, Xiaolei Pei, Lei Zhang

Blood (2025) 146 (Supplement 1): 1293.

https://doi.org/10.1182/blood-2025-1293

Published: 2025

Journal Articles

Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)

Chen Yunfei, Sun Ting, Yanmei Xu, Feng Xue, Xiaofan Liu, Wei Liu, Rongfeng Fu, Mankai Ju, Wenjing Gu, Xinyue Dai, Huan Dong, Renchi Yang, Lei Zhang

Blood (2025) 146 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2025-4813

Published: 2025

Journal Articles

Artificial Intelligence-Based Quantitative Bone Marrow Pathology Analysis for Myeloproliferative Neoplasms

Dandan Yu, Hong-Ju Zhang, Yanyan Song, Yuan Tao, Fengyuan Zhou, Ziyi Wang, Rongfeng Fu, Ting Sun, Huan Dong, Wenjing Gu, Renchi Yang, Zhijian Xiao, Qi Sun, Lei Zhang

Blood (2024) 144 (Supplement 1): 3182.

https://doi.org/10.1182/blood-2024-201265

Published: 2024

Journal Articles

A Prospective Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Lusutrombopag in Chinese Adults with Persistent or Chronic Primary Immune Thrombocytopenia

Rongfeng Fu, Xiaofan Liu, Xinmiao Qu, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Huan Dong, Wenjing Gu, Xinyue Dai, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 5438.

https://doi.org/10.1182/blood-2024-204932

Published: 2024

Journal Articles

A Novel F12 Gene Pathogenic Mutation Identified in a Consanguineous Pedigree with Clustered Thrombotic and Pulmonary Disease

Xinmiao Qu, Xiaofan Liu, Rongfeng Fu, Yujiao Jia, Yuhua Wang, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Huan Dong, Wenjing Gu, Xinyue Dai, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 5558.

https://doi.org/10.1182/blood-2024-202375

Published: 2024

Journal Articles

Sex-Specific Impact on Disease Outcome and Mutational Landscape in Essential Thrombocythemia

Chen Jia, Huan Dong, Ting Sun, Rongfeng Fu, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 1824.

https://doi.org/10.1182/blood-2023-173112

Published: 2023

Journal Articles

An Innovative Dynamic Nomogram for Stratifying Survival Prognosis in Essential Thrombocythemia Patients with a History of Thrombosis

Chen Jia, Ting Sun, Rongfeng Fu, Huan Dong, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 6390.

https://doi.org/10.1182/blood-2023-173111

Published: 2023

Journal Articles

Acquired Hemophilia a: A Single-Center Study of 165 Patients

Dandan Yu, Feng Xue, Xiaofan Liu, Yunfei Chen, Rongfeng Fu, Ting Sun, Xinyue Dai, Mankai Ju, Huan Dong, Renchi Yang, Wei Liu, Lei Zhang

Blood (2023) 142 (Supplement 1): 2623.

https://doi.org/10.1182/blood-2023-173407

Published: 2023

Journal Articles

A Single-Center Study of Patients with Isolated Acquired Clotting Factor Deficiency: Clinical Features, Treatments, and Prognosis

Dandan Yu, Feng Xue, Xiaofan Liu, Yunfei Chen, Rongfeng Fu, Ting Sun, Xinyue Dai, Mankai Ju, Huan Dong, Renchi Yang, Wei Liu, Lei Zhang

Blood (2023) 142 (Supplement 1): 3995.

https://doi.org/10.1182/blood-2023-173431

Published: 2023

Journal Articles

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Wei Liu, Rongfu Zhou, Panjing Wang, Hu Zhou, Jie Bai, Xianghua Wang, Yueshen Ma, Zhen Song, Yunfei Chen, Xiaofan Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Xinyue Dai, Huan Dong, Feng Xue, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 2628.

https://doi.org/10.1182/blood-2023-174587

Published: 2023

Journal Articles

Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial

Blood (2023) 142 (Supplement 1): 687.

https://doi.org/10.1182/blood-2023-174591

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Prophylaxis CTLA4-ig reduces anti-AAV neutralizing antibodies in AAV gene therapy for hemophilia

Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)

Artificial Intelligence-Based Quantitative Bone Marrow Pathology Analysis for Myeloproliferative Neoplasms

A Prospective Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Lusutrombopag in Chinese Adults with Persistent or Chronic Primary Immune Thrombocytopenia

A Novel F12 Gene Pathogenic Mutation Identified in a Consanguineous Pedigree with Clustered Thrombotic and Pulmonary Disease

Sex-Specific Impact on Disease Outcome and Mutational Landscape in Essential Thrombocythemia

An Innovative Dynamic Nomogram for Stratifying Survival Prognosis in Essential Thrombocythemia Patients with a History of Thrombosis

Acquired Hemophilia a: A Single-Center Study of 165 Patients

A Single-Center Study of Patients with Isolated Acquired Clotting Factor Deficiency: Clinical Features, Treatments, and Prognosis

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only